Bridgeway Capital Management’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-63,300
| Closed | -$80.4K | – | 1448 |
|
|
2023
Q2 | $80.4K | Hold |
63,300
| – | – | ﹤0.01% | 1286 |
|
|
2023
Q1 | $88.6K | Buy |
63,300
+30,000
| +90% | +$42K | ﹤0.01% | 1259 |
|
|
2022
Q4 | $125K | Sell |
33,300
-35,000
| -51% | -$131K | ﹤0.01% | 1186 |
|
|
2022
Q3 | $333K | Sell |
68,300
-10,000
| -13% | -$48.8K | 0.01% | 1002 |
|
|
2022
Q2 | $730K | Hold |
78,300
| – | – | 0.02% | 794 |
|
|
2022
Q1 | $499K | Hold |
78,300
| – | – | 0.01% | 937 |
|
|
2021
Q4 | $676K | Buy |
+78,300
| New | +$676K | 0.01% | 896 |
|